Dr. Akpaka Kalu, WHO Regional Advisor for Tropical and Vector-borne Disease, said positive results from ongoing pilot programs of malaria vaccinations in three African countries - Ghana, Malawi and Kenya - had led the organization to recommend widespread use of RTS,S/AS0 or Mosquirix among children in sub-Saharan Africa. 'The datasets that were generated in these studies and field trials were by African scientists,' Kalu said. The vaccine, a product of 30 years of research, was developed by British drug manufacturer […]
